Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiency

The objective of the study was the characterization of ABCA1 gene mutations in 10 patients with extremely low HDL-cholesterol. Five patients (aged 6months to 76years) presented with splenomegaly and thrombocytopenia suggesting the diagnosis of Tangier disease (TD). Three of them were homozygous for...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular genetics and metabolism 2012-11, Vol.107 (3), p.534-541
Hauptverfasser: Fasano, Tommaso, Zanoni, Paolo, Rabacchi, Claudio, Pisciotta, Livia, Favari, Elda, Adorni, Maria Pia, Deegan, Patrick B., Park, Adrian, Hlaing, Thinn, Feher, Michael D., Jones, Ben, Uzak, Asli Subasioglu, Kardas, Fatih, Dardis, Andrea, Sechi, Annalisa, Bembi, Bruno, Minuz, Pietro, Bertolini, Stefano, Bernini, Franco, Calandra, Sebastiano
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The objective of the study was the characterization of ABCA1 gene mutations in 10 patients with extremely low HDL-cholesterol. Five patients (aged 6months to 76years) presented with splenomegaly and thrombocytopenia suggesting the diagnosis of Tangier disease (TD). Three of them were homozygous for novel mutations either in intron (c.4465-34A>G) or in exons (c.4376delT and c.5449C>T), predicted to encode truncated proteins. One patient was compound heterozygous for a nucleotide insertion (c.1758_1759insG), resulting in a truncated protein and for a nucleotide substitution c.4799A>G, resulting in a missense mutation (p.H1600R). The last TD patient, found to be heterozygous for a known mutation (p.D1009Y), had a complete defect in ABCA1-mediated cholesterol efflux in fibroblasts, suggesting the presence of a second undetected mutant allele. Among the other patients, four were asymptomatic, but one, with multiple risk factors, had severe peripheral artery disease. Three of these patients were heterozygous for known mutations (p.R130K+p.N1800H, p.R1068C, p.N1800H), while two were carriers of novel mutations (c.1195-27G>A and c.396_397insA), predicted to encode truncated proteins. The pathogenic effect of the two intronic mutations (c. 1195-27G>A and c.4465-34A>G) was demonstrated by the analysis of the transcripts of splicing reporter mutant minigenes expressed in COS-1 cells. Both mutations activated an intronic acceptor splice site which resulted in a partial intron retention in mature mRNA with the production of truncated proteins. This study confirms the allelic heterogeneity of TD and suggests that the diagnosis of TD must be considered in patients with an unexplained splenomegaly, associated with thrombocytopenia and hypocholesterolemia. ► ABCA1 mutations were identified in 10 patients with low plasma HDL-C levels. ► Five patients had Tangier disease and five had Familial HDL deficiency. ► Seven novel ABCA1 mutations were identified: 5 in exons and 2 in introns. ► The exonic mutations produced deleterious missense or nonsense mutations. ► The intronic mutations generated abnormally spliced mRNA encoding truncated proteins.
ISSN:1096-7192
1096-7206
DOI:10.1016/j.ymgme.2012.08.005